Figure 2. Cumulative mortality after GCLAC for patients who had not yet undergone transplant (“pre-transplant”) vs. mortality of all patients, including those who received allogeneic stem cell transplant after GCLAC.
Cumulative mortality was higher after patients had undergone allogeneic stem cell transplant.